What are the latest liver cancer drugs?

Liver cancer is a disgusting tumor that occurs in the liver. There are primary liver cancer and metastatic liver cancer. The liver cancer that people often talk about in their daily lives generally refers to primary liver cancer. Primary liver cancer is one of the most common malignant tumors. So what are the latest liver cancer drugs? Let's take a look below.

The drugs for treating liver cancer are generally the following: 1. Eruption Pills: Eruption Pills are the first choice for treating liver cancer ascites. They can balance the metabolism of water and salt and prevent electrolyte disorders. Eruption Pills can fundamentally improve the symptoms of liver cancer ascites, enhance the patient's immune function, and then completely treat the repeated growth of liver cancer ascites. 2. Huachansu Oral Liquid: The toad aglycone and Huachansu essence contained in Huachansu Oral Liquid have extraordinary anti-cancer effects. The anti-cancer activity of this ingredient is comparable to the paclitaxel and camptothecin anticancer drugs currently used in clinical practice. It is safe and has no side effects and can effectively treat liver cancer metastasis and recurrence. 3. Cidan Capsules: Lincidan Capsules can not only effectively kill cancer cells, but also improve human immune function. It has a strong tumor inhibition effect, can directly kill cancer cells, effectively soften and shrink tumors, and protect the body's immune resistance. Cidan Capsules have no obvious side effects and are suitable for long-term use. 4. Zhenxiang Capsules: Zhenxiang Capsules have a high degree of inhibition and killing effects on cancer cells, gradually shrinking tumors. It is suitable for the treatment of early, middle and late stage cancers of various types of cancer. It can prevent recurrence and metastasis when used before and after surgery, radiotherapy and chemotherapy.

Advanced liver cancer can be treated with Nexavar (sorafenib), which can be used for the clinical treatment of patients with unresectable hepatocellular carcinoma or liver cancer. Nexavar has a new dual mechanism, which can directly inhibit tumor growth on the one hand, and block the formation of tumor angiogenesis on the other hand, indirectly inhibiting the growth of tumor cells. It is a drug that can significantly prolong the overall survival of patients with advanced hepatocellular carcinoma or primary liver cancer by 44%.

For the treatment of liver cancer, it is necessary to first confirm the stage of the cancer in order to adopt the best treatment method and determine the best treatment drug. In addition, the choice of early treatment plan will greatly affect the later recovery effect of liver cancer patients. Therefore, early detection, early diagnosis, and early treatment are particularly important.